Technical Trend Overview and Price Movement
TTK Healthcare’s current price stands at ₹897.50, up from the previous close of ₹883.35, marking a daily increase of 1.60%. The stock’s 52-week high is ₹1,402.00, while the low is ₹737.00, indicating a wide trading range over the past year. The recent technical trend has shifted from outright bearish to mildly bearish, reflecting a tentative improvement in price momentum but still under pressure.
The daily moving averages remain mildly bearish, suggesting that short-term price action is yet to confirm a sustained uptrend. This is corroborated by the monthly MACD, which remains bearish, indicating that the longer-term momentum is still weak. Conversely, the weekly MACD and KST (Know Sure Thing) indicators have turned mildly bullish, hinting at some short-term positive momentum building.
MACD and Momentum Indicators
The Moving Average Convergence Divergence (MACD) indicator presents a nuanced view. On a weekly basis, the MACD is mildly bullish, signalling a potential short-term recovery in momentum. However, the monthly MACD remains bearish, underscoring that the stock’s longer-term trend is still under strain. This divergence between weekly and monthly MACD readings suggests that while short-term traders might find opportunities, longer-term investors should remain cautious.
The KST indicator aligns with this view, showing mild bullishness on the weekly chart but bearishness on the monthly timeframe. This mixed momentum profile indicates that the stock is in a transitional phase, with short-term technicals improving but longer-term trends yet to confirm a reversal.
RSI and Bollinger Bands Analysis
The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in neutral territory. This lack of directional RSI momentum suggests that the stock is neither overbought nor oversold, leaving room for either a continuation of the current trend or a reversal depending on upcoming market catalysts.
Bollinger Bands provide further insight. On the weekly chart, the bands are mildly bullish, indicating that price volatility is supporting a modest upward momentum. However, the monthly Bollinger Bands remain mildly bearish, reflecting broader caution and potential resistance at higher price levels.
Volume and On-Balance Volume (OBV) Trends
Volume-based indicators add another layer of complexity. The On-Balance Volume (OBV) shows no clear trend on the weekly chart but is mildly bearish on the monthly timeframe. This suggests that despite some short-term buying interest, the overall volume flow is not strongly supporting a sustained rally. Investors should monitor volume closely, as a decisive increase could validate the emerging short-term bullish signals.
Comparative Performance Against Sensex
TTK Healthcare’s returns have lagged behind the broader market benchmark, the Sensex, across multiple timeframes. Over the past week, the stock declined by 1.30% while the Sensex gained 1.73%. The one-month return was nearly flat at -0.11%, compared to the Sensex’s 1.30% rise. Year-to-date, the stock has fallen 13.34%, underperforming the Sensex’s 11.37% gain. Over one year, the underperformance is more pronounced, with TTK Healthcare down 29.05% versus the Sensex’s 7.55% decline.
Longer-term returns also highlight challenges. Over three years, the stock is down 28.55%, while the Sensex has surged 20.41%. Even over five years, TTK Healthcare’s 36.23% gain trails the Sensex’s 43.93%. The 10-year return is negative at -2.04%, starkly contrasting with the Sensex’s 183.56% growth. This performance gap emphasises the stock’s struggle to keep pace with broader market gains, reflecting sector-specific or company-level headwinds.
Momentum building strong! This Mid Cap from NBFC is on our MomentumNow radar. Other investors are catching on – will you join?
- - Building momentum strength
- - Investor interest growing
- - Limited time advantage
Moving Averages and Dow Theory Signals
Daily moving averages remain mildly bearish, indicating that the stock’s short-term price action has yet to break decisively above key resistance levels. This is a cautionary sign for traders looking for confirmation of a trend reversal. Meanwhile, Dow Theory analysis on both weekly and monthly charts shows no clear trend, reflecting indecision in the market about the stock’s directional bias.
Mojo Score and Rating Update
TTK Healthcare’s current Mojo Score stands at 42.0, categorised as a Sell rating. This represents a downgrade from the previous Hold rating, effective from 21 July 2025. The downgrade reflects deteriorating technical and fundamental parameters, signalling caution for investors. The company is classified as a micro-cap within the diversified sector, which often entails higher volatility and risk.
Given the mixed technical signals and underwhelming relative performance, the Sell rating aligns with the need for prudence. Investors should weigh the mildly bullish short-term indicators against the prevailing bearish longer-term momentum before making allocation decisions.
TTK Healthcare Ltd. or something better? Our SwitchER feature analyzes this micro-cap Diversified stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Investor Takeaway and Outlook
TTK Healthcare Ltd. currently presents a challenging technical and fundamental landscape. While short-term momentum indicators such as weekly MACD and KST show mild bullishness, the dominant monthly signals remain bearish. The absence of clear RSI signals and the mildly bearish moving averages suggest that the stock is in a consolidation phase, with no definitive trend established.
Relative underperformance against the Sensex across all key timeframes further emphasises the stock’s struggle to gain investor favour. The downgrade to a Sell rating and a Mojo Score of 42.0 reflect these concerns. Investors should approach the stock with caution, considering the mixed technical signals and the broader market context.
For those seeking exposure to the diversified sector, it may be prudent to monitor TTK Healthcare for a confirmed technical turnaround before committing capital. Alternatively, exploring other micro-cap or mid-cap stocks with stronger momentum and fundamentals could offer better risk-adjusted returns.
Summary of Key Technical Indicators for TTK Healthcare Ltd.
- Technical Trend: Shifted from Bearish to Mildly Bearish
- MACD: Weekly Mildly Bullish, Monthly Bearish
- RSI: No clear signal on Weekly and Monthly charts
- Bollinger Bands: Weekly Mildly Bullish, Monthly Mildly Bearish
- Moving Averages: Daily Mildly Bearish
- KST: Weekly Mildly Bullish, Monthly Bearish
- Dow Theory: No clear trend on Weekly and Monthly
- OBV: No trend Weekly, Mildly Bearish Monthly
- Mojo Score: 42.0 (Sell), downgraded from Hold on 21 Jul 2025
In conclusion, TTK Healthcare Ltd. remains a stock to watch closely, with technical momentum showing tentative signs of improvement but longer-term bearishness persisting. Investors should balance these signals carefully within their portfolio strategies.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
